Metabolomic characterization of myocardial ischemia-reperfusion injury in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention.
Adolescent
Adult
Aged
Biomarkers
Comorbidity
Computational Biology
/ methods
Female
Humans
Male
Metabolomics
/ methods
Middle Aged
Myocardial Reperfusion Injury
/ diagnosis
Percutaneous Coronary Intervention
/ methods
ROC Curve
ST Elevation Myocardial Infarction
/ complications
Time Factors
Treatment Outcome
Young Adult
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
13 08 2019
13 08 2019
Historique:
received:
20
11
2018
accepted:
16
07
2019
entrez:
15
8
2019
pubmed:
15
8
2019
medline:
27
10
2020
Statut:
epublish
Résumé
The aim of the study was to discover the metabolomic changes in plasma that occur during human Ischemia-Reperfusion (I/R) injury and to evaluate the diagnostic utility of plasma metabolomic biomarkers for determination of myocardial injury. Deciphering the details of plasma metabolome in ST-segment elevation myocardial infarction (STEMI) patients before and after primary percutaneous coronary interventions (PPCI) would allow for better understanding of the mechanisms involved during acute myocardial ischemia and reperfusion in humans. We performed a detailed non-targeted metabolomic analysis of plasma from 27 STEMI patients who had undergone PPCI in the first 48 hrs employing a LC-MS approach. Plasma metabolome at ischemic condition was compared to multiple time points after PPCI which allowed us to focus on changes in the reperfusion phase. Classification of the differential metabolites based on chemical taxonomy identified a major role for lipids and lipid-derived molecules. Biochemical pathway analysis identified valine, leucine and isoleucine biosynthesis, vitamin B6 metabolism and glutathione metabolism as the most significant metabolic pathways representing early response to I/R injury. We also identified phenyl alanine, tyrosine, linoleic acid and glycerophospholipid metabolism as the most significant pathways representing late response to I/R injury. A panel of three metabolites pentadecanoic acid, linoleoyl carnitine and 1-linoleoylglycerophosphocholine was discovered to have diagnostic value in determining the extent of I/R injury based on cardiac biomarkers. Using a non-targeted LC-MS approach, we have successfully generated the most comprehensive data to date on significant changes in the plasma metabolome in STEMI patients who had undergone PPCI in the first 48 hrs showing that lipid metabolites represent the largest cohort of molecules undergoing significant change.
Identifiants
pubmed: 31409856
doi: 10.1038/s41598-019-48227-9
pii: 10.1038/s41598-019-48227-9
pmc: PMC6692400
doi:
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
11742Références
J Am Coll Cardiol. 2015 Apr 21;65(15):1509-20
pubmed: 25881932
Prog Lipid Res. 2004 Jan;43(1):55-90
pubmed: 14636671
Eur J Nutr. 2016 Apr;55(3):1213-23
pubmed: 26009005
Ann Biom Biostat. 2013 Jul 5;1(1):
pubmed: 25045756
J Pharmacol Exp Ther. 2002 May;301(2):543-50
pubmed: 11961055
Circulation. 2004 Feb 3;109(4):465-70
pubmed: 14732748
Sci Rep. 2016 Nov 08;6:36359
pubmed: 27821850
Nucleic Acids Res. 2007 Jan;35(Database issue):D521-6
pubmed: 17202168
Am J Clin Nutr. 2007 Oct;86(4):929-37
pubmed: 17921367
J Am Coll Cardiol. 2016 Sep 20;68(12):1281-93
pubmed: 27634119
Arch Intern Med. 2012 Mar 26;172(6):502-8
pubmed: 22371874
Circ Heart Fail. 2014 Jul;7(4):634-42
pubmed: 24762972
Adv Nutr. 2016 Jul 15;7(4):730-4
pubmed: 27422507
J Clin Lab Anal. 2009;23(1):45-50
pubmed: 19140211
Circulation. 2017 Nov 14;136(20):1908-1919
pubmed: 28844989
Korean J Lab Med. 2009 Feb;29(1):1-9
pubmed: 19262072
Circulation. 2005 Dec 20;112(25):3868-75
pubmed: 16344383
Mol Cell Biochem. 1998 Mar;180(1-2):65-73
pubmed: 9546632
Free Radic Biol Med. 1998 Aug;25(3):329-39
pubmed: 9680179
Cardiovasc Res. 2019 Jan 1;115(1):179-189
pubmed: 29850765
Bioinformatics. 2010 Sep 15;26(18):2342-4
pubmed: 20628077
Eur J Nutr. 2018 Feb;57(1):297-308
pubmed: 27770189
Arterioscler Thromb Vasc Biol. 2007 Nov;27(11):2463-9
pubmed: 17766330
J Am Coll Cardiol. 2004 Sep 15;44(6):1210-4
pubmed: 15364321
J Lipid Res. 2008 Sep;49(9):1990-2000
pubmed: 18503030
JAMA. 2010 Jun 2;303(21):2148-55
pubmed: 20516415
Physiol Rev. 2010 Jan;90(1):207-58
pubmed: 20086077
Mass Spectrom Rev. 2007 Jan-Feb;26(1):51-78
pubmed: 16921475
J Clin Invest. 2013 Jan;123(1):92-100
pubmed: 23281415
J Am Heart Assoc. 2018 Apr 6;7(8):
pubmed: 29626151
Biochem J. 2016 May 1;473(9):1191-202
pubmed: 26936967
N Engl J Med. 2007 Sep 13;357(11):1121-35
pubmed: 17855673
Nutr Metab Cardiovasc Dis. 2018 Jan;28(1):44-52
pubmed: 28986077
Am J Med. 1975 Oct;59(4):464-9
pubmed: 1166854
Eur J Clin Nutr. 2004 May;58(5):718-24
pubmed: 15116074
Nucleic Acids Res. 2008 Jan;36(Database issue):D684-8
pubmed: 18084021
Pac Symp Biocomput. 2016;21:120-31
pubmed: 26776179
Sci Rep. 2019 Jan 22;9(1):312
pubmed: 30670713
CMAJ. 2005 Nov 8;173(10):1191-202
pubmed: 16275971